Expected results and impact

The AIROPico network will affirm the leading position of Europe in the human picornavirus research field. AIROPico will take the transfer of knowledge in this field a step further by facilitating in the exchange of researchers and expanding the research groups by hiring new researchers. This lays down a fundament for commercialization of theoretical knowledge and sustainable economic growth. More specific, it will result in several products to be used in the clinic.


Expected societal benefits

The new cost efficient diagnostic tools and therapeutics for picornaviruses that are developed within AIROPico will improve patient care and faster recovery of patients suffering from picornavirus infections. The earlier detection and improved treatment of picornaviruses will reduce the strain on healthcare institutions and decreases workforce dropout.